BioOhio: Materials and presentations from past BioOhio events



	Featuring links to bioscience presentations delivered at events previously sponsored or promoted by BioOhio. 2007 BioOhio Annual Conference: Focus on Devices & Diagnostics Held on Nov. 12-13, featuring national and local speakers including the FDA's Don St. Pierre and AdvaMed's Amy Jensen Cunniffe. View agenda and available presentations Bioscience in Ohio: An Economic Driver Workforce-focused presentation by BioOhio Sr. Director Bill Tacon at the Project Lead The Way Fall Conference on Oct. 22, 2007, on the campus of Case Western Reserve University. See PowerPoint slide show Capital from the Capitols How to Secure Public Financing to Support Bioscience Companies Presented by BioOhio and BioOhio-member Hicks Partners, LLC, on 2/12/07 and 5/22/07, this workshop provided an overview of funding programs offered by the State of Ohio and Federal government aimed at supporting the research, development and commercialization activities of bioscience companies. Panelists included: Khisha Fallon of Senator George Voinovich’s office; Bob Clark of Congressman Dave Hobson’s office; Diane Wilkinson of U.S. Senator Sherrod Brown's office; and Robert Mullen of U.S. Congressman Ralph Regula's office. Click to view the following materials shared at the workshop: Federal Appropriations and Grants Overview (slideshow) \| Bioscience Appropriations Bill Grid \| FY2008 Appropriations Request Questionnaire - Voinovich \| CRS Report for Congress: Grants \| FY2008 Project Questionnaire - Regula \| Appropriations Request Form - Brown \| Messaging for Success An Industrial Perspective on Bioscience Careers Presentation by BioOhio Sr. Program Director Bill Tacon for Ohio State University life science graduate students on May 17, 2007. See PowerPoint slide show Global Partnering with Ohio’s Market Leaders in conjunction with BIO 2007 Annual Convention Partnering, outsourcing, and strategic alliances have become vital to the success of bioscience and pharmaceutical firms, including the growth-oriented bioscience corporations in Ohio. This breakfast seminar was held in Boston on May 7 to provide BIO conventioneers insight into what executives from P&G Pharmaceuticals, P&G Bioscience, Meridian Bioscience, and Diagnostic Hybrids are looking for in 2007. Click to view the following PowerPoint presentations: Jeff Davis, head of Global New Business Development, P&G Pharmaceuticals Darren Ji, director of Business Development Asia, P&G Bioscience Jack Kraeutler, president, Meridian Bioscience BioPharma in Ohio II Positioning Ohio as a Pipeline State Co-presented by BioOhio and PhRMA on Feb. 28, 2007, the conference brought together the individuals and organizations in Ohio that currently serve or partner with the pharmaceutical industry to discuss the global trends of R&D outsourcing and strategic alliances. Click to view the following PowerPoint presentations: David K. Rosen, D.V.M., Head, Development & Commercial Strategic Alliances, Pfizer Global Research & Development Chuck McOsker, Ph.D., Director, Business Development & External Relations, Genome Research Institute, University of Cincinnati Tony Dennis, Ph.D., President & CEO, BioOhio Bioscience Agri-Business, Convergence & Endless Opportunities Presentation by BioOhio Vice President John F. Lewis, Jr., at the Ohio Plant Bio Consortium, held at OARDC on October 28, 2006. See slides in PDF Driving Technology Convergence through Collaboration – Bioinformatics Presentation by BioOhio President & CEO Tony Dennis, PhD, at the Ohio Collaborative Conference on Bioinformatics, held at Ohio University on June 29, 2006. See slides in PDF BioPharma in Ohio: A Prescription for Growth Afternoon event held on March 21, 2006, focused on building the pharmaceutical industry in Ohio. View agenda Listen to mp3s of the afternoon speakers and panelists: Keynote Address mp3 Gino Santini, Senior Vice President, Corporate Strategy & Policy, Eli Lilly & Company Panel One: Filling the Pipeline mp3 (Moderator) John Rice, Ph.D., Managing Partner, Triathlon Medical Ventures Gil Van Bokkelen, Chairman, President & CEO, Athersys, Inc. Bruce M. Pratt, Ph.D., Vice President for Science Development, Genzyme Corporation Wayne Hoss, Ph.D., Interim CEO, Cognitive Pharmaceuticals Panel Two: Made in Ohio mp3 (Moderator) State Senator Kimberly A. Zurz, Assistant Minority Leader, Ohio Senate Frank E. Samuel, Jr., Science & Technology Advisor, Governor’s Office of Science & Technology James B. Krimmel, Immediate Past Chairman & Representative, Third Frontier Advisory Board, Ohio Manufacturers’ Association (OMA) Reed Vickerman, Vice President, Corporate Services, Amylin Pharmaceuticals, Inc. The Ohio BioRepository: A Community Hospital Focused Tissue Repository Presentation by BioOhio's Bill Tacon, PhD, at Windows of the Future Conference, March 7, 2006. See slides in PDF Biotech Business & Technology Exchange: Marketing and PR strategy for emerging bioscience companies Columbus Technology Council event held on March 28, 2005, featuring Dennis Brown, Director, Technology Marketing, Fahlgren-Mortine. See slides in PDF Why Ohio? Come Grow with Us Targeted bioscience asset-based attraction data presented by BioOhio staff at several regional economic development events throughout Ohio in February and March. See slides in PDF (2MB) or 4-page summary Ohio BioRepository: A Foundation for Ohio's Future Presentation delivered by BioOhio Senior Program Director Bill Tacon, PhD, at Case Western Reserve University on February 24, 2005. See slides in PDF (4MB) BioOhio 2004: Entrepreneurs & Innovation View presentations. Biotech Exchange BioVentures: Attracting the Best to Columbus Held on June 16, 2004 at the Columbus Children's Hospital Research Institute. View presentation from: John A. Barnard, MD, Children’s Hospital Research Institute, VP for Scientific Affairs, Center for Cell & Vascular Biology Ohio Bioscience Regulatory Forum Held on May 26, 2004, a half-day seminar featuring FDA speaker Dan Schultz, MD, Acting Director for the Center for Devices and Radiological Health, who delivered his perspective on “The Changing World of Medical Devices” from the nation’s capitol. Richard Schwen, PhD, senior regulatory consultant at PAREXEL International, discussed the “fast track” process for drug testing and approval, and other subjects of current interest; and Barbara Fant, PharmD, Clinical Research Consultants, talked about reducing risk by integrating clinical strategies throughout the medical device lifecycle. View Fant presentation (3MB) View Schultz presentation (2MB) View Schwen presentation (133K) Ohio Bioscience Statehouse Day On May 11, 2004 Omeris Board members, bioscience executives, Senate and House Bioscience Caucus members and other state policymakers met for lunch and a look at the state of the Bioscience Industry in Ohio. Speakers included: Tony Dennis, PhD, Omeris; Mark Collar, P&G Pharmaceuticals; David Scholl, PhD, Diagnostic Hybrids; Fred Sanfilippo, MD, PhD, The Ohio State University; John Rice, PhD, Triathlon Medical Ventures; State Senator Steve Stivers; and State Representative Tim Schaffer See slides Ohio Bioscience & The Pharmaceutical Industry: A Partnership for Cures David Brennan, AstraZeneca U.S. president and CEO, and Mark Heeson, president of the National Venture Capital Association, joined Ohio bioscience, pharmaceutical, and investment firm executives in a discussion of industry issues and Ohio's emergence as a bioscience leader. The 2-hour program was held September 4, 2003 at the Adam's Mark, Columbus. Click here for David Brennan's speech and photos from the event.